Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2012-04-03 Director's Dealing
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 3 pages 119.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y' and is a 'Change of Director's Interest Notice' under ASX listing rule 3.19A.2. It details the change in securities held by a director, including the number of shares before and after the change, the nature of the change, and other related information. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It does not contain financial performance data, management discussion, or other report types. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement or a certification but a formal notice of director's share transactions.
2012-04-03 English
Change of Director`s Interest Notice 2 pages 120.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act, which relate to disclosures of changes in directors' interests in securities. The content details the director's name, date of last notice, nature of interest changes, securities held before and after the change, and other related information. There is no financial performance data, earnings information, or management discussion. The document is a formal notification of a director's personal share transactions, consistent with insider trading disclosures. Therefore, this document fits the category of Director's Dealing (DIRS). The document length is 3696 characters, which is typical for such notices and not a report or announcement of a report.
2012-04-03 English
Change of Director`s Interest Notice 2 pages 118.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares and options held before and after the change, nature of the change, and dates. This is a clear report of personal share transactions by a company director. The document length is 3547 characters, which is consistent with a detailed director's dealing notice rather than a brief announcement or other report type. There is no indication of financial results, management discussion, or other report content. Therefore, the document fits the definition of Director's Dealing (DIRS).
2012-04-03 English
Shareholder Newsletter 4 pages 384.0KB
Management Reports Classification · 95% confidence The document is a detailed shareholder update newsletter from March 2012, discussing company strategy, partnerships, commercial progress, and a new board appointment. It includes extensive narrative on business developments, collaborations, financial support, and strategic outlook. It is not a formal annual or quarterly financial report, nor an earnings release or audit report. It is not a transcript of a call, nor a regulatory filing or voting announcement. The document contains substantive business and management information, including a board director appointment, but the primary focus is on business progress and strategy rather than solely on board changes. Given the detailed management discussion and strategic update to shareholders, this fits best as a Management Reports (MDA) filing type, which covers management's detailed explanation of business trends and outlook. The document length and content support this classification with high confidence.
2012-03-04 English
Director appointment 2 pages 38.5KB
Board/Management Information Classification · 100% confidence The document is an announcement from Phylogica Ltd regarding the appointment of Jeremy Curnock Cook as a Non-Executive Director. It details his background, roles, and the company's comments on his appointment. There is no financial data, no report or presentation attached, and no mention of voting results or other regulatory filings. The content focuses solely on a change in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 4704 characters, which is sufficient for a detailed announcement but not a full report.
2012-02-29 English
Initial Director`s Interest Notice 2 pages 47.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held or contracts noted. This is a report of personal share transactions or interests by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director interests, not financial results or other report types.
2012-02-29 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.